Lymphadenopathy after the third Covid-19 vaccine

Summary: Axillary lymphadenopathy ipsilateral to the vaccination site has been clinically and radiologically reported after administration of COVID-19 vaccines. This can be an important diagnostic dilemma, particularly in cancer patients who are being staged or re-staged, as this benign entity may m...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Can Özütemiz, David A. Potter, Ayça Özbek Özütemiz, Daniel Steinberger
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Covid 19 vaccine vaccination booster lymphadenopathy mRNA Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/d6019e48c91048eebe76bf854fbe65f2
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:d6019e48c91048eebe76bf854fbe65f2
record_format	dspace
spelling	oai:doaj.org-article:d6019e48c91048eebe76bf854fbe65f22021-11-06T04:36:45ZLymphadenopathy after the third Covid-19 vaccine2666-621910.1016/j.cpccr.2021.100127https://doaj.org/article/d6019e48c91048eebe76bf854fbe65f22021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2666621921000752https://doaj.org/toc/2666-6219Summary: Axillary lymphadenopathy ipsilateral to the vaccination site has been clinically and radiologically reported after administration of COVID-19 vaccines. This can be an important diagnostic dilemma, particularly in cancer patients who are being staged or re-staged, as this benign entity may mimic metastasis, cause unnecessary biopsies and changes in therapy. Here we present a breast cancer patient and a patient with squamous cell carcinoma of the head and neck, who had already received the first two doses of mRNA type COVID-19 vaccines before, now presenting with new hypermetabolic reactive lymphadenopathy on FDG PET/CT after the third booster dose.Can ÖzütemizDavid A. PotterAyça Özbek ÖzütemizDaniel SteinbergerElsevierarticleCovid 19vaccinevaccinationboosterlymphadenopathymRNANeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENCurrent Problems in Cancer: Case Reports, Vol 4, Iss , Pp 100127- (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Covid 19 vaccine vaccination booster lymphadenopathy mRNA Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
spellingShingle	Covid 19 vaccine vaccination booster lymphadenopathy mRNA Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Can Özütemiz David A. Potter Ayça Özbek Özütemiz Daniel Steinberger Lymphadenopathy after the third Covid-19 vaccine
description	Summary: Axillary lymphadenopathy ipsilateral to the vaccination site has been clinically and radiologically reported after administration of COVID-19 vaccines. This can be an important diagnostic dilemma, particularly in cancer patients who are being staged or re-staged, as this benign entity may mimic metastasis, cause unnecessary biopsies and changes in therapy. Here we present a breast cancer patient and a patient with squamous cell carcinoma of the head and neck, who had already received the first two doses of mRNA type COVID-19 vaccines before, now presenting with new hypermetabolic reactive lymphadenopathy on FDG PET/CT after the third booster dose.
format	article
author	Can Özütemiz David A. Potter Ayça Özbek Özütemiz Daniel Steinberger
author_facet	Can Özütemiz David A. Potter Ayça Özbek Özütemiz Daniel Steinberger
author_sort	Can Özütemiz
title	Lymphadenopathy after the third Covid-19 vaccine
title_short	Lymphadenopathy after the third Covid-19 vaccine
title_full	Lymphadenopathy after the third Covid-19 vaccine
title_fullStr	Lymphadenopathy after the third Covid-19 vaccine
title_full_unstemmed	Lymphadenopathy after the third Covid-19 vaccine
title_sort	lymphadenopathy after the third covid-19 vaccine
publisher	Elsevier
publishDate	2021
url	https://doaj.org/article/d6019e48c91048eebe76bf854fbe65f2
work_keys_str_mv	AT canozutemiz lymphadenopathyafterthethirdcovid19vaccine AT davidapotter lymphadenopathyafterthethirdcovid19vaccine AT aycaozbekozutemiz lymphadenopathyafterthethirdcovid19vaccine AT danielsteinberger lymphadenopathyafterthethirdcovid19vaccine
_version_	1718443886006763520

Lymphadenopathy after the third Covid-19 vaccine

Ejemplares similares